Abbot Financial Management, Inc. G1 Therapeutics, Inc. Transaction History

Abbot Financial Management, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$10.16 - $16.17 $108,204 - $172,210	-10,650 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$13.16 - $22.47 $140,154 - $239,305	10,650 New	10,650 $143,000
Q2 2021 Aug 05, 2021	SELL	$19.57 - $26.32 $169,280 - $227,668	-8,650 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$17.58 - $32.59 $152,066 - $281,903	8,650 New	8,650 $208,000
Q3 2020 Oct 26, 2020	SELL	$11.55 - $23.75 $96,442 - $198,312	-8,350 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$9.57 - $24.37 $79,909 - $203,489	8,350 New	8,350 $203,000
Q1 2020 May 12, 2020	SELL	$9.07 - $26.32 $77,548 - $225,036	-8,550 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$20.54 - $31.0 $175,617 - $265,050	8,550 New	8,550 $226,000
Q3 2019 Nov 13, 2019	SELL	$22.78 - $40.58 $194,769 - $346,959	-8,550 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$16.03 - $31.1 $137,056 - $265,905	8,550 New	8,550 $262,000
Q4 2018 Feb 07, 2019	SELL	$16.51 - $51.33 $145,288 - $451,704	-8,800 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$35.06 - $51.17 $10,518 - $15,351	300 Added 3.53%	8,800 $382,000
Q1 2018 May 02, 2018	BUY	$19.05 - $41.76 $161,925 - $354,960	8,500 New	8,500 $315,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Abbot Financial Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Abbot Financial Management, Inc. with notifications on news.